EUVIMEDEUVIMED entdecken
Crossref

A Dual-Function LipoAraN-E5 Coloaded with N 4 -Myristyloxycarbonyl-1-β- d -arabinofuranosylcytosine (AraN) and a CXCR4 Antagonistic Peptide (E5) for Blocking the Dissemination of Acute Myeloid Leukemia

Xuelei Wang, Xiaowei Wang, Jiayi Su, Dan Wang, Wenkai Feng, Xiaobo Wang, Hongwei Lu, Apeng Wang, Mingliang Liu iD, Guimin Xia iD

ACS Nano · 15.10.2024 · 18 (41) · 27917-27932

DOI: 10.1021/acsnano.4c05079 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 04.10.2024. Verfasst von Xuelei Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, P. R. China. Hauptthemen laut MEDLINE: Receptors, CXCR4, Leukemia, Myeloid, Acute, Cytarabine, Cell Proliferation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Chinese Academy of Medical Sciences, Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute myeloid leukemia (AML) is a hematological malignancy with a high recurrence rate. The interaction of chemokine receptor 4/chemokine ligand 12 (CXCR4/CXCL12) mediates homing and adhesion of AML cells in bone marrow, leading to minimal residual disease in patients, which brings a hidden danger for future AML recurrence. Ara-C is a nonselective chemotherapeutic agent against AML. Due to its short half-life and severe side effects, a lipid-like Ara-C derivative (AraN) was synthesized and a dual-function LipoAraN-E5 (135 nm, encapsulation efficiency 99%) was developed, which coloaded AraN and E5, a peptide of the CXCR4 antagonist. LipoAraN-E5 effectively improved the uptake, enhanced the inhibition of leukemia cell proliferation, migration, and adhesion to stromal cells in bone marrow, and mobilized the leukemia cells from bone marrow to peripheral blood via interfering with the CXCR4/CXCL12 axis. LipoAraN-E5 prolonged the plasma half-life of AraN (8.31 vs 0.56 h) and was highly enriched in peripheral blood (3.67 vs 0.05 μmol/g at 8 h) and bone marrow (379 vs 148 μmol/g at 24 h). LipoAraN-E5 effectively prevented the infiltration of leukemia cells in peripheral blood, bone marrow, spleen, and liver, prolonged the mice survival, and showed outstanding antineoplastic efficacy with negligible toxicity, which were attributed to the ingenious design of AraN, the use of a liposomal delivery carrier, and the introduction of E5. Our work revealed that LipoAraN-E5 may be a promising nanocandidate against AML.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, CXCR4Leukemia, Myeloid, AcuteCytarabineCell ProliferationAnimalsHumansMiceAntineoplastic AgentsPeptidesCell MovementCell Line, Tumor

Stichwörter der Autor:innen

Ara-CCXCR4acute myeloid leukemiadrug deliveryliposome

Substanzen

Receptors, CXCR4CytarabineAntineoplastic AgentsCXCR4 protein, humanPeptides

Autor:innen und Institutionen

  • Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, P. R. China.

ORCID-Profile: Mingliang Liu, Guimin Xia

Förderung

  • Chinese Academy of Medical Sciences
  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Wang, X., Wang, X., Su, J., Wang, D., Feng, W., Wang, X., Lu, H., Wang, A., Liu, M., & Xia, G. (2024). A Dual-Function LipoAraN-E5 Coloaded with N 4 -Myristyloxycarbonyl-1-β- d -arabinofuranosylcytosine (AraN) and a CXCR4 Antagonistic Peptide (E5) for Blocking the Dissemination of Acute Myeloid Leukemia. ACS Nano, 18(41), 27917-27932. https://doi.org/10.1021/acsnano.4c05079

Vancouver

Wang X, Wang X, Su J, Wang D, Feng W, Wang X, et al. A Dual-Function LipoAraN-E5 Coloaded with N 4 -Myristyloxycarbonyl-1-β- d -arabinofuranosylcytosine (AraN) and a CXCR4 Antagonistic Peptide (E5) for Blocking the Dissemination of Acute Myeloid Leukemia. ACS Nano. 2024;18(41):27917-27932. doi:10.1021/acsnano.4c05079

BibTeX
@article{Wang2024,
  author = {Wang, Xuelei and Wang, Xiaowei and Su, Jiayi and Wang, Dan and Feng, Wenkai and Wang, Xiaobo and Lu, Hongwei and Wang, Apeng and Liu, Mingliang and Xia, Guimin},
  title = {A Dual-Function LipoAraN-E5 Coloaded with N 4 -Myristyloxycarbonyl-1-β- d -arabinofuranosylcytosine (AraN) and a CXCR4 Antagonistic Peptide (E5) for Blocking the Dissemination of Acute Myeloid Leukemia},
  journal = {ACS Nano},
  year = {2024},
  volume = {18},
  number = {41},
  pages = {27917--27932},
  doi = {10.1021/acsnano.4c05079}
}
Kostenlos starten →